Metas Biomedical Inc.

02/07/2026

｜𝗛𝗮𝗽𝗽𝘆 𝟭𝟰𝘁𝗵 𝗔𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆 𝘁𝗼 𝗠𝗲𝘁𝗮𝘀 𝗕𝗶𝗼𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗜𝗻𝗰.｜

Today, we are delighted to celebrate 14 years of dedication, innovation, and global partnership.🎉

We sincerely thank our partners, clients, and team members for being an essential part of our journey. Your trust and support have inspired us to continuously expand our global reach and strengthen our commitment to better healthcare.

Over the past 14 years, we have remained committed to connecting innovative healthcare technologies with healthcare professionals and patients around the world. Together, we have achieved:

🌍 Delivered medical devices and diagnostic solutions to 𝟮𝟱+ 𝗰𝗼𝘂𝗻𝘁𝗿𝗶𝗲𝘀
🏥 Distributed 𝟭𝟬+ 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗽𝗿𝗼𝗱𝘂𝗰𝘁 𝗹𝗶𝗻𝗲𝘀
🤝 Built long-term partnerships and delivered 𝘁𝗮𝗶𝗹𝗼𝗿𝗲𝗱 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 to meet the specific needs of our distributors
🩺 Established a 𝗼𝗻𝗲-𝘀𝘁𝗼𝗽 𝗶𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗲𝗱 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗽𝗹𝗮𝘁𝗳𝗼𝗿𝗺

As we celebrate this milestone, we remain committed to creating value through innovation, collaboration, and trusted partnerships.

From today onward, we will continue delivering better healthcare solutions for a healthier future. We look forward to 𝘄𝗲𝗹𝗰𝗼𝗺𝗶𝗻𝗴 𝗺𝗼𝗿𝗲 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀 to join us on this exciting journey.

Thank you for being part of our story. Here's to the next chapter of growth, innovation, and making a lasting difference in healthcare worldwide.

08/06/2026

08/06/2026

｜Welcoming Our Valued Partner from Thailand｜

We were honored to welcome our valued clients from Thailand, together with our supplier partners, for a productive business discussion and training session on the use of single-use bronchoscopes.

The program provided an excellent platform for hands-on learning, professional knowledge sharing, and meaningful discussions among healthcare professionals. We were able to exchange valuable clinical experiences and market insights, fostering mutual learning and strengthening regional collaboration in respiratory care.

We sincerely thank all participating clients, physicians, and supplier partners for their engagement and contributions to the success of this event. Your commitment to advancing healthcare innovation continues to inspire us.

At Metas Biomedical, we remain dedicated to bridging innovative healthcare technologies with local markets in countries of interest. By understanding the specific needs and conditions of each market, we strive to deliver integrated solutions that support healthcare professionals and improve patient care outcomes across the region.

18/12/2025

｜2025 Annual Congress of Taiwan Society of Pulmonary and Critical Care Medicine｜

Metas Biomedical had the privilege of participating in the 𝟮𝟬𝟮𝟱 𝗔𝗻𝗻𝘂𝗮𝗹 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 𝗼𝗳 𝗧𝗮𝗶𝘄𝗮𝗻 𝗦𝗼𝗰𝗶𝗲𝘁𝘆 𝗼𝗳 𝗣𝘂𝗹𝗺𝗼𝗻𝗮𝗿𝘆 𝗮𝗻𝗱 𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗖𝗮𝗿𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲 with our trusted suppliers, where we engaged with a wide range of highly respected medical professionals.

During the event, we were pleased to showcase the advanced medical device, the 𝗛𝗼𝗿𝘂𝘀 𝗦𝗶𝗻𝗴𝗹𝗲-𝗨𝘀𝗲 𝗕𝗿𝗼𝗻𝗰𝗵𝗼𝘀𝗰𝗼𝗽𝗲, and received valuable hands-on insights from experienced physicians. Their clinical expertise helped us deepen our understanding of the product’s real-world application. We were grateful to learn that doctors expressed a high level of satisfaction with its performance, usability, and clinical value especially highlighting its 𝘀𝗵𝗮𝗿𝗽𝗲𝗿, 𝗵𝗶𝗴𝗵-𝗿𝗲𝘀𝗼𝗹𝘂𝘁𝗶𝗼𝗻 𝗶𝗺𝗮𝗴𝗲 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 to support the detection of subtle abnormalities in the airways.

Through live discussions and demonstrations, physicians shared how the Horus Bronchoscope is utilized across 𝗺𝘂𝗹𝘁𝗶𝗽𝗹𝗲 𝗵𝗼𝘀𝗽𝗶𝘁𝗮𝗹 𝘀𝗰𝗲𝗻𝗮𝗿𝗶𝗼𝘀, enhancing our perspective from a practical, patient-care standpoint. Their insights were essential in confirming the Horus Bronchoscope’s relevance and effectiveness in modern airway management.

Physicians highlighted the use of single-use bronchoscopes in the following airway management procedures:
• High infection-risk cases
• Cancer interventions (commonly laser procedures)
• Consecutive phlegm suction
• Airway/bronchial stent placement
• Tracheostomy procedures
• Intensive Care Unit (ICU) settings

We are encouraged by the growing adoption of single-use bronchoscopes across major hospitals and clinical settings. These devices offer clear advantages for physicians, including 𝗶𝗺𝗺𝗲𝗱𝗶𝗮𝘁𝗲 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗶𝗹𝗶𝘁𝘆, 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗵𝗶𝗴𝗵 𝗰𝗮𝘀𝗲 𝘁𝘂𝗿𝗻𝗼𝘃𝗲𝗿, and 𝗿𝗲𝗱𝘂𝗰𝗲𝗱 𝗻𝗲𝗲𝗱 𝗳𝗼𝗿 𝗿𝗲𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴, particularly in emergency and ICU settings. They are also well suited for 𝘀𝗽𝗲𝗰𝗶𝗮𝗹𝗶𝘇𝗲𝗱 𝗽𝗿𝗼𝗰𝗲𝗱𝘂𝗿𝗲𝘀 such as 𝗹𝗮𝘀𝗲𝗿 𝗶𝗻𝘁𝗲𝗿𝘃𝗲𝗻𝘁𝗶𝗼𝗻𝘀, helping clinicians avoid costly camera damage to reusable equipment.

From a patient perspective, single-use bronchoscopes play a critical role in 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗰𝗼𝗻𝘁𝗿𝗼𝗹 by minimizing the risk of cross-contamination while delivering 𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝘁 𝗮𝗻𝗱 𝗿𝗲𝗮𝗹-𝘁𝗶𝗺𝗲 𝗯𝗲𝗱𝘀𝗶𝗱𝗲 𝗽𝗲𝗿𝗳𝗼𝗿𝗺𝗮𝗻𝗰𝗲. Together, these benefits contribute to safer procedures and improved overall patient outcomes.

We are grateful for the opportunity to collaborate with the medical community, learn from their clinical experience, and introduce the advancing solutions through our global distribution network. If you would like to learn more about how this single-use model supports safer and more effective patient care, please 𝗳𝗲𝗲𝗹 𝗳𝗿𝗲𝗲 𝘁𝗼 𝗰𝗼𝗻𝘁𝗮𝗰𝘁 𝘂𝘀. We would be happy to share more details.

03/10/2025

｜𝗧𝗿𝗮𝗶𝗻𝗶𝗻𝗴 𝗦𝗲𝘀𝘀𝗶𝗼𝗻 𝗳𝗼𝗿 𝗕𝗿𝗼𝗻𝗰𝗵𝗼𝘀𝗰𝗼𝗽𝗲｜

This week, our sales team had the incredible opportunity to take part in a comprehensive medical device training session with our long-term trusted suppliers. We had an in-depth discussion regarding latest medical advancements including 𝗼𝗻𝗲-𝘁𝗶𝗺𝗲 𝘂𝘀𝗲 𝗯𝗿𝗼𝗻𝗰𝗵𝗼𝘀𝗰𝗼𝗽𝗲 which has recently been added to our expanding product portfolio.

Learning directly from the experts behind the technology not only deepens our product knowledge, but also sharpens our ability to serve our clients with confidence and professionalism. Understanding the science, safety, and innovation that go into each device equips us to communicate real value to healthcare providers and, ultimately, patients.

At the heart of great sales is great understanding and this kind of hands-on, expert-led training is exactly what empowers us to deliver this cutting-edge disposable bronchoscope, supporting 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻 𝗰𝗼𝗻𝘁𝗿𝗼𝗹 and improving treatment quality.

30/12/2024

｜𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗘𝘅𝗽𝗼 𝗧𝗮𝗶𝘄𝗮𝗻 𝟮𝟬𝟮𝟰｜

We are honored to have participated in the 8th Healthcare Expo Taiwan 2024, held in Taipei from December 5 to 8. This groundbreaking event showcased Taiwan’s remarkable advancements in biomedicine, research, technology, and innovation, featuring cutting-edge medical devices poised to address diverse global healthcare needs. The four-day expo serves as a vital platform for us to stay updated on the latest healthcare market trends, explore innovative medical products, seek potential collaboration opportunities, and reconnect with partners and peers in the industry. We are grateful to have taken part in this exceptional event and its key activities:

👨‍⚕️𝗧𝗵𝗲 𝟰𝘁𝗵 𝗔𝘀𝗶𝗮 𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗙𝗼𝗿𝘂𝗺 𝗼𝗻 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗖𝗮𝗻𝗰𝗲𝗿 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁
Our participation began with the Asia Pacific Forum on Precision Cancer Treatment, where we gained valuable insights, practical knowledge, and up-to-date guidance from both domestic and international physicians on advanced approaches to the precise treatment of lung and breast cancers. Asia faces the highest global lung cancer burden, with 65.7% of cases in Taiwan occurring among non-smokers.

Next-Generation Sequencing (NGS) was highlighted as an effective technology for analyzing tumor tissue or liquid biopsy samples to identify targeted mutations. These findings enable precision cancer treatment approaches based on a patient’s specific genetic profile. Common somatic mutations in lung cancers include alterations in the EGFR, KRAS, and TP53, genes. While breast cancer requires an integrated analysis involving DNA (e.g., PIK3CA, ESR1, BRCA1/2), RNA, proteomes (e.g., HER2), exosomes, and circulating tumor cells (CTCs). It was noted that many pertinent pathways in breast cancer do not have gene mutations. Additionally, circulating tumor DNA (ctDNA) has proven valuable for detecting minimal residual disease (MRD) and predicting late recurrence.

While precision cancer treatments offer significant benefits to patients, all speakers indicated the challenges posed by high costs and limited health coverage. Critical decisions—such as selecting single-gene testing, limited panels, or whole-genome sequencing, as well as choosing between tissue-agnostic and tissue-informed therapies—require further consideration and development.

👨‍💻𝗠𝗲𝗲𝘁𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗯𝘂𝘆𝗲𝗿 𝗳𝗿𝗼𝗺 𝗦𝗼𝘂𝘁𝗵 𝗔𝗳𝗿𝗶𝗰𝗮
We had the privilege of meeting with an international buyer from South Africa, who engaged in a productive discussion about our products and potential market opportunities. After demonstrating our offerings, the buyer expressed interest in connecting us with individuals likely to benefit from our solutions.

We further discussed emerging trends in the African medical sector, identifying key market gaps for future business opportunities. The buyer also shared details about the products he is seeking, and we are pleased to explore sourcing these items from the Taiwanese market on his behalf, strengthening our global reach and contributing to healthcare advancement worldwide.

🎯𝗞𝗲𝘆 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗺𝗮𝗿𝗸𝗲𝘁 𝘁𝗿𝗲𝗻𝗱𝘀, 𝘀𝘂𝗰𝗵 𝗮𝘀 𝗽𝗿𝗲𝗰𝗶𝘀𝗲 𝘁𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗮𝗻𝗱 𝗱𝗶𝗴𝗶𝘁𝗮𝗹 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲
While exploring the exhibition in search of innovative technological devices, we discovered several fascinating approaches to addressing various health issues.

- Electrical Nerve Stimulation: Expanding its application to treat chronic diseases such as diabetes and inflammatory bowel disease (IBD).
- F***l Microbiota Transplant (FMT): Utilized for treating gastrointestinal diseases like Clostridium difficile (C. diff) infection and Colitis.
- Integrated Medical Imaging Solutions: Combining 3D image, AI, and endoscopic systems to enhance image analysis, surgical efficiency and precision.
- Human-derived Exosomes: Emerging as a novel regenerative medicine therapy to treat a variety of conditions, such as skin wounds, bone disorders, and organs injuries or fibrosis.
- Smart Hospital Solutions: Leveraging Artificial Intelligence of Things (AIoT) and telemedicine to improve healthcare quality and management efficiency.

We are grateful to be part of this ever-evolving biomedicine sector. Each year, we observe a remarkable progression of cutting-edge technological devices presented at this esteemed exhibition. It is truly inspiring to witness the dedication of the companies in this field, who consistently demonstrate a strong commitment to excellence and a deep sense of responsibility. We deeply appreciate the opportunity to collaborate with these trusted partners, working together to improve lives and provide the highest quality healthcare to individuals across the globe.

20/03/2024

｜Arab Health 2024 in Dubai｜

Arab Health 2024 proved to be an exceptional platform for us to showcase our innovative biomedical products and forge meaningful connections within the healthcare community from the Middle East. Our participation in this pivotal event enabled us to engage with a diverse range of healthcare professionals, such as doctors, medical consultants, professional distributors, and industry experts from across the Middle East and beyond. We absolutely treasure this experience and enjoyed meeting our new potential customers.

Through our interactive demonstrations and insightful discussions, we were able to show how committed we are to advancing healthcare through groundbreaking biomedical technologies across all medical fields.

Our successful experience at Arab Health not only elevated our presence but also facilitated valuable collaborations and partnerships that potentially allow us to contribute to healthcare across the Middle East.

Metas Biomedical Inc. would like to thank you all for visiting our booth and we look forward to building on our positive interaction to continuously make a meaningful impact in the field of biomedicine together.

28/01/2024

｜Arab Health 2024 in Dubai｜

Today marks the beginning of Arab Health in Dubai! We extend a warm invitation to visit us at booth C52 in Hall Z1, where we will showcase our cutting-edge medical devices such as the , , , , and an extensive array of rapid tests, including the .

Furthermore, as a customer-oriented company, we offer tailored services through our initiative. If you are looking for a specific product not currently in our portfolio, simply visit "https://www.metasbiomedical.com/inquiry.html" to submit your inquiry. We will source it for you or explore the possibility of customization to meet your needs.

Your insights and feedback are invaluable to us, and we are eager to discuss how our products and service can best complement your needs and goals. Please let us know your availability during Arab Health so that we can make the necessary arrangements to ensure our meeting is both productive and beneficial.

We look forward to the possibility of meeting with you at Arab Health and exploring opportunities for future collaboration.

01/11/2023

｜MEDICA 2023 in Germany｜

The world's leading trade fair for medical technology, MEDICA 2023, is just around the corner, and we are thrilled to announce that we will be showcasing our cutting-edge medical devices: the , , , and an extensive range of rapid tests, including the . This exciting event will take place in Dusseldorf, Germany from November 13th to 16th.

If you are also planning to attend this significant industry gathering, we believe it presents an excellent opportunity for us to connect and provide you with a product demonstration. Your insights and feedback are invaluable to us, and we are eager to discuss how our products can best complement your needs and goals. Please let us know your availability during MEDICA so that we can make the necessary arrangements to ensure our meeting is both productive and beneficial.

We look forward to the possibility of meeting with you at MEDICA and exploring opportunities for future collaboration.